Floatz logo

Flutamide

Congenital Adrenal Hyperplasia (CAH)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Small moleculePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

12 Active assets in the Congenital Adrenal Hyperplasia (CAH) cohort.

Asset / SponsorPhaseRating
Solu-Cortef
University of Texas Southwestern Medical Center
Phase 4A
Cortisone
Federico II University
Phase 4BBB
Atumelnant
Crinetics Pharmaceuticals Inc.
Phase 3BB
FLUDROCORTISONE
University of Texas Southwestern Medical Center
Phase 3BB
DEXAMETHASONE
Shanghai Jiao Tong University School of Medicine
Phase 4BB

View all 21 →

Same molecule, other indications

Flutamide is also rated in:

prostate cancerDormant
BB
Indicative ·
68 / 100
View asset →
prostate adenocarcinomaDormant
BB
Indicative ·
68 / 100
View asset →
prostate neoplasmDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →